人白细胞干扰素在带状疱疹中的应用。I. 安全性、循环抗病毒活性及宿主对感染的反应。 - Suppr

Suppr

超能文献

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.

作者信息

Jordan G W, Fried R P, Merigan T C

出版信息

J Infect Dis. 1974 Jul;130(1):56-62. doi: 10.1093/infdis/130.1.56.

DOI:10.1093/infdis/130.1.56

PMID:4601181

Abstract

摘要

相似文献

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.人白细胞干扰素在带状疱疹中的应用。I. 安全性、循环抗病毒活性及宿主对感染的反应。

J Infect Dis. 1974 Jul;130(1):56-62. doi: 10.1093/infdis/130.1.56.

Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial.阿糖胞苷在一项对照试验中对播散性带状疱疹的不良反应。

N Engl J Med. 1973 Oct 25;289(17):873-8. doi: 10.1056/NEJM197310252891701.

Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.霍奇金病及其他感染水痘或牛痘的癌症患者的皮肤干扰素产生

N Engl J Med. 1970 Nov 26;283(22):1182-7. doi: 10.1056/NEJM197011262832202.

Herpes zoster-varicella infection in malignant lymphomas. Influence of splenectomy and intensive treatment.

Eur J Cancer (1965). 1975 Jan;11(1):51-7. doi: 10.1016/0014-2964(75)90037-7.

Interferon, antibody, and other host factors in herpes zoster.带状疱疹中的干扰素、抗体及其他宿主因素。

J Clin Invest. 1972 May;51(5):1170-8. doi: 10.1172/JCI106910.

Herpes zoster: recent studies.带状疱疹：近期研究

Natl Cancer Inst Monogr. 1973 May;36:465-8.

[Generalized herpes zoster in Hodgkin's disease. (Case report and immunological studies)].

Z Haut Geschlechtskr. 1966 Aug 1;41(3):85-90.

Herpes zoster--the best approach.带状疱疹——最佳治疗方法。

Med Times. 1980 Jun;108(6):47-52.

Human leukocyte interferon for the treatment of herpes zoster in patients with cancer.人白细胞干扰素用于治疗癌症患者的带状疱疹。

N Engl J Med. 1978 May 4;298(18):981-7. doi: 10.1056/NEJM197805042981801.

Triple drug therapy of Herpes zoster infection occurring in patients with reticulo-endothelial neoplasia--a preliminary study.网状内皮组织增生症患者发生带状疱疹感染的三联药物治疗——一项初步研究。

J Antimicrob Chemother. 1980 Nov;6(6):733-6. doi: 10.1093/jac/6.6.733.

引用本文的文献

You Shall Not Pass: MX2 Proteins Are Versatile Viral Inhibitors.你不得通过：MX2蛋白是多功能病毒抑制剂。

Vaccines (Basel). 2023 May 3;11(5):930. doi: 10.3390/vaccines11050930.

Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.人 MX2/MxB：一种有效的干扰素诱导的疱疹病毒和 HIV-1 的进入后抑制剂。

J Virol. 2018 Nov 27;92(24). doi: 10.1128/JVI.00709-18. Print 2018 Dec 15.

Biological response modifiers and infectious diseases: actual and potential therapeutic agents.生物反应调节剂与传染病：实际与潜在的治疗药物。

Int J Antimicrob Agents. 1994;3(4):223-43. doi: 10.1016/0924-8579(94)90050-7.

Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.中枢阿片系统参与人α干扰素诱导的小鼠强迫游泳试验中的不动行为。

Br J Pharmacol. 2000 Jul;130(6):1269-74. doi: 10.1038/sj.bjp.0703432.

Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.人成纤维细胞和白细胞干扰素在兔体内的药代动力学特性。

J Clin Microbiol. 1980 Jan;11(1):102-5. doi: 10.1128/jcm.11.1.102-105.1980.

The failure of human leukocyte interferon to influence the growth of human glioma cell populations: in vitro and in vivo studies.人白细胞干扰素对人胶质瘤细胞群体生长的影响：体外和体内研究

Br J Cancer. 1983 Dec;48(6):819-25. doi: 10.1038/bjc.1983.272.

Human lymphoblastoid interferon in the treatment of small cell lung cancer.人淋巴母细胞干扰素治疗小细胞肺癌

Br J Cancer. 1983 Mar;47(3):361-6. doi: 10.1038/bjc.1983.54.

The interferons.干扰素

Clin Exp Immunol. 1983 Oct;54(1):1-13.

Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.干扰素与干扰素诱导剂：临床应用的发展及治疗前景

Drugs. 1982 Jan-Feb;23(1-2):37-55. doi: 10.2165/00003495-198223010-00002.

Antiviral agents: an update--Part 2.抗病毒药物：最新进展——第2部分。

Indian J Pediatr. 1980 Nov-Dec;47(389):515-22. doi: 10.1007/BF02822541.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验